Luckwel Pharmaceuticals Inc. (LWEL) Financial Statements
Luckwel Pharmaceuticals Inc. (LWEL) files with the U.S. Securities and Exchange Commission under CIK 0001567098. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2021
- Net Income
- -$436.01 thousand
- Total Assets
- $46.68 thousand
- Net Cash from Operations
- -$197.97 thousand
Fiscal year ended Mar 31, 2021. Latest periodic SEC filing: Sep 9, 2021. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for LWEL in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History